Senators Ask ORA To Halt Lab Closure Pending Congressional Review
This article was originally published in The Tan Sheet
Executive Summary
The Office of Regulatory Affairs' plan to close FDA labs should "undergo congressional review" according to a letter 20 senators sent to Commissioner Andrew von Eschenbach Jan. 30
You may also be interested in...
Dingell Says Lab Closures “Frightening,” FDA District Chief Expects Problems
House Energy and Commerce leaders say FDA's plan to close several labs - including its only facility testing for radiological contaminants - is a threat to national security, while an FDA district chief says problems are likely to hinder the agency's work early in the planned reorganization
Dingell Says Lab Closures “Frightening,” FDA District Chief Expects Problems
House Energy and Commerce leaders say FDA's plan to close several labs - including its only facility testing for radiological contaminants - is a threat to national security, while an FDA district chief says problems are likely to hinder the agency's work early in the planned reorganization
Dingell Says Lab Closures “Frightening,” FDA District Chief Expects Problems
House Energy and Commerce leaders say FDA's plan to close several labs - including its only facility testing for radiological contaminants - is a threat to national security, while an FDA district chief says problems are likely to hinder the agency's work early in the planned reorganization